These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28494629)

  • 1. Cisplatin and paclitaxel co-delivered by folate-decorated lipid carriers for the treatment of head and neck cancer.
    Yang J; Ju Z; Dong S
    Drug Deliv; 2016 Nov; 24(1):792-799. PubMed ID: 28494629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folate-modified, cisplatin-loaded lipid carriers for cervical cancer chemotherapy.
    Zhang G; Liu F; Jia E; Jia L; Zhang Y
    Drug Deliv; 2016 May; 23(4):1393-7. PubMed ID: 26165422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin-guided nanotherapy: a lipid-based nanomedicine for targeted drug delivery in breast cancer therapy.
    Lin M; Teng L; Wang Y; Zhang J; Sun X
    Drug Deliv; 2016 May; 23(4):1420-5. PubMed ID: 26203688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted Nanostructured Lipid Carriers for Delivery of Paclitaxel to Cancer Cells: Preparation, Characterization, and Cell Toxicity.
    Rezazadeh M; Emami J; Hassanzadeh F; Sadeghi H; Rostami M; Mohammadkhani H
    Curr Drug Deliv; 2017; 14(8):1189-1200. PubMed ID: 28472908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Gastric Cancer Peptide GX1-Modified Nano-Lipid Carriers Encapsulating Paclitaxel: Design and Evaluation of Anti-Tumor Activity.
    Jian Y; Zhao M; Cao J; Fan T; Bu W; Yang Y; Li W; Zhang W; Qiao Y; Wang J; Wen A
    Drug Des Devel Ther; 2020; 14():2355-2370. PubMed ID: 32606603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted lung cancer therapy: preparation and optimization of transferrin-decorated nanostructured lipid carriers as novel nanomedicine for co-delivery of anticancer drugs and DNA.
    Shao Z; Shao J; Tan B; Guan S; Liu Z; Zhao Z; He F; Zhao J
    Int J Nanomedicine; 2015; 10():1223-33. PubMed ID: 25709444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanocarrier-Based Combination Chemotherapy for Resistant Tumor: Development, Characterization, and Ex Vivo Cytotoxicity Assessment.
    Raikwar S; Vyas S; Sharma R; Mody N; Dubey S; Vyas SP
    AAPS PharmSciTech; 2018 Nov; 19(8):3839-3849. PubMed ID: 30280350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic combination therapy of lung cancer: Cetuximab functionalized nanostructured lipid carriers for the co-delivery of paclitaxel and 5-Demethylnobiletin.
    Guo S; Zhang Y; Wu Z; Zhang L; He D; Li X; Wang Z
    Biomed Pharmacother; 2019 Oct; 118():109225. PubMed ID: 31325705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted delivery of etoposide to cancer cells by folate-modified nanostructured lipid drug delivery system.
    Zhang S; Lu C; Zhang X; Li J; Jiang H
    Drug Deliv; 2016 Jun; 23(5):1838-45. PubMed ID: 26879035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-delivery of baicalein and doxorubicin by hyaluronic acid decorated nanostructured lipid carriers for breast cancer therapy.
    Liu Q; Li J; Pu G; Zhang F; Liu H; Zhang Y
    Drug Deliv; 2016 May; 23(4):1364-8. PubMed ID: 25874959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein-Inspired Nanocarrier Composed of Folic Acid-Modified Protein and Lipids: Preparation and Evaluation of Tumor-Targeting Effect.
    Han M; Ji X; Li J; Ge Z; Luo B; Zhou K; Wang Q; Sun X; Zhang W; Li J
    Int J Nanomedicine; 2020; 15():3433-3445. PubMed ID: 32523342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery.
    Zhang L; Zhu D; Dong X; Sun H; Song C; Wang C; Kong D
    Int J Nanomedicine; 2015; 10():2101-14. PubMed ID: 25844039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and optimization of transferrin-conjugated nanostructured lipid carriers for brain delivery of paclitaxel using Box-Behnken design.
    Emami J; Rezazadeh M; Sadeghi H; Khadivar K
    Pharm Dev Technol; 2017 May; 22(3):370-382. PubMed ID: 27689412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel-loaded Nanolipidic Carriers with Improved Oral Bioavailability and Anticancer Activity against Human Liver Carcinoma.
    Harshita ; Barkat MA; Rizwanullah M; Beg S; Pottoo FH; Siddiqui S; Ahmad FJ
    AAPS PharmSciTech; 2019 Jan; 20(2):87. PubMed ID: 30675689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and evaluation of novel tumor-targeting paclitaxel-loaded nano-carriers for ovarian cancer treatment: in vitro and in vivo.
    Yao S; Li L; Su XT; Wang K; Lu ZJ; Yuan CZ; Feng JB; Yan S; Kong BH; Song K
    J Exp Clin Cancer Res; 2018 Feb; 37(1):29. PubMed ID: 29478415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanostructured lipid carriers based temozolomide and gene co-encapsulated nanomedicine for gliomatosis cerebri combination therapy.
    Chen Z; Lai X; Song S; Zhu X; Zhu J
    Drug Deliv; 2016 May; 23(4):1369-73. PubMed ID: 26017099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual-Drug Nanosystem: Etoposide Prodrug and Cisplatin Coloaded Nanostructured Lipid Carriers for Lung Cancer Therapy.
    Du M; Yin J
    Drug Des Devel Ther; 2022; 16():4139-4149. PubMed ID: 36506793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo evaluation of folate-mediated PEGylated nanostructured lipid carriers for the efficient delivery of furanodiene.
    Zhang J; He Y; Jiang J; Li M; Jin C; Wang L; Wang D
    Drug Dev Ind Pharm; 2017 Oct; 43(10):1610-1618. PubMed ID: 28481661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxorubicin- and cisplatin-loaded nanostructured lipid carriers for breast cancer combination chemotherapy.
    Di H; Wu H; Gao Y; Li W; Zou D; Dong C
    Drug Dev Ind Pharm; 2016 Dec; 42(12):2038-2043. PubMed ID: 27184819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic Acid and Poly(ethylene glycol) Decorated Paclitaxel Nanocrystals Exhibit Enhanced Stability and Breast Cancer-Targeting Capability.
    Zhao J; Du J; Wang J; An N; Zhou K; Hu X; Dong Z; Liu Y
    ACS Appl Mater Interfaces; 2021 Mar; 13(12):14577-14586. PubMed ID: 33728919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.